Top Marijuana Stocks To Buy This Month
Are you looking for the best marijuana stocks to buy this month? If the answer is yes here is what you should know about the sector and the cannabis industry. To begin most marijuana stocks trade with a high level of volatility. This means that as quickly as the sector can rise is as fast as it can drop. So with this, it can be tough at times to see sustained trading. But there are those who are able still to take profits from these quick rises in trading. Currently, this up and down trading is still evident for most marijuana stocks. However, there are several catalysts that could help the sector see better trading. During August some cannabis companies will begin to release earnings. Hopefully, with strong reports, it will help add some positive sentiment to the sector.
As well there is the continued push to end cannabis prohibtion which many feel will be the reason the sector sees a big run. Now, none of the above market catalysts are set in stone as guaranteed market movers. However, history has shown that progress on federal reform and positive earnings can help increase momentum for most marijuana stocks. Still, the industry is still fairly young and developing. This gives more chances to those looking to invest in the legal cannabis space. So with much left to be done and seen for the overall industry legal cannabis is moving on the right path. The companies below are just a few marijuana stocks to watch this month.
Marijuana Stocks To Watch Right Now
Canopy Growth Corporation
Canopy Growth Corporation together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. Back on July 28th, the company announced its new premium flower line. Which is said to be perfect for summer staycations and weekends away.
These new premium flower offerings from 7ACRES and Doja demonstrate Canopy Growth’s commitment to continued innovation. As well as continuing to strengthen its leading position in the premium flower category.
Words From The Company
“Cannabis connoisseurs know what they want: premium products that over-deliver on aroma and flavor, while still hitting the THC mark,” said Julian Cohen, Chief Innovation Officer at Canopy Growth. “Our focus on innovation allows us to give consumers the enhanced quality attributes and range of products they’re looking for. As Canadians from coast-to-coast prepare for the long weekend, we’re excited to offer them new premium options to enjoy at home or at their favorite summer destination.”
[Read More] 2 Marijuana Stocks To Buy Today?
Tilray Brands, Inc.
Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. In recent news, the company has reported its record fiscal year 2022 results.
Highlights And Key Mentions
- Fourth Quarter International Cannabis Increased 205% from the Prior Year Q4; Tilray Medical Leads European Medical Cannabis Market with 20% Market Share in Germany
- Delivered $85 Million in Cost Savings to Date, Exceeding Original Target on Accelerated Timeline; Company Now Expects to Deliver $100 Million by the End of FY2023
- Significantly Strengthened Balance Sheet, Reduced Debt, and Ended FY2022 with $416 Million in Cash
- Tilray Brands Sets Stage for Next Evolution of Cannabis Following HEXO Transaction, which Positions the Company for Additional Growth Opportunities in Canada, Europe, and the U.S
MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | firstname.lastname@example.org